Abstract

Aim. To study the main relationships of the white coat effect (WCE) levels in patients with arterial hypertension (AH) with bronchial asthma (BA) who treated with AH and BA drugs in routine clinical practice.Material and Methods. We analyzed the prospective cohort study data of AH patients, some of them had BA without exacerbation. We have formed two groups of patients:1 - control group, patients with AH without BA, the second - with AH + BA. The study consisted of three visits (first visit, 6 months and 12 months visits) and data collection period (30.1±7.6 months of follow-up). The following procedures were performed at the first and 12 month visits: clinical blood pressure (BP) measurements (sitting and standing), 24-hour monitoring ambulatory (ABPM), spirometry, clinical and biochemical blood tests, BA control questionnaires (ACQ) and quality of life (QL) questionnaire (GWBQ), at the second visit clinical BP measurement was performed and, if necessary, the drug dose was corrected.Results. The study included 125 patients, 28 men, 97 women. The first group of AH patients without BA included 85 people, the second (AH + BA) - 40. In AH patients without BA with ischemic heart disease, arterial revascularization, regular alcohol intake and smoking we identified the association with the lower WCE levels. In AH+BA patients with diabetes mellitus, gastrointestinal diseases, higher education was identified WCE decrease. In AH patients without asthma we found inverse relationships WCE levels with respiratory function parameters, the nighttime BP decrease, heart rate and the difference between standing and sitting BP levels, and correlations with the EchoCG variables (the left ventricular hypertrophy (LVH) indices), with age, AH duration and body mass index (BMI). In patients with AH + BA we found inverse correlations between WCE levels and some EchoCG variables, the difference between standing and sitting BP levels, and correlations with body weight, BMI.Conclusion. Thereby, in AH patients without BA with ischemic heart disease, revascularization, regular alcohol intake, smoking we identified the association with the lower WCE levels. This patients WCE indices had inverse correlations with height, respiratory function parameters, the BP nighttime decrease, the difference between standing and sitting BP levels and direct relationships with EchoCG variables of LVH, age, AH duration and BMI. In AH + BA patients with diabetes, gastrointestinal diseases, higher education we found relationships with lesser WCE manifestation. WCE levels in this group had inverse correlations with some EchoCG indicators, the standing and sitting BP difference and direct relations with weight and BMI.

Highlights

  • In arterial hypertension (AH) patients without bronchial asthma (BA) with ischemic heart disease, arterial revascularization, regular alcohol intake and smoking we identified the association with the lower white coat effect (WCE) levels

  • In AH patients without asthma we found inverse relationships WCE levels with respiratory function parameters, the nighttime blood pressure (BP) decrease, heart rate and the difference between standing and sitting BP levels, and correlations with the EchoCG variables (the left ventricular hypertrophy (LVH) indices), with age, AH duration and body mass index (BMI)

  • In patients with AH + BA we found inverse correlations between WCE levels and some EchoCG variables, the difference between standing and sitting BP levels, and correlations with body weight, BMI

Read more

Summary

Материал и методы

Исследование состояло из двух частей: длительное наблюдение, состоящее из трех визитов (исходный визит, через 6 и 12 мес) и периода сбора данных об исходах (30,1±7,6 мес наблюдения). Впоследствии для проспективного исследования из этих пациентов было сформировано две группы: 1 группа пациентов с АГ без БА, 2 группа – АГ в сочетании с БА. Критерии включения: 1) информированное согласие больного на участие в исследовании; 2) возраст от 30 до 79 лет; 3) ГБ I-III стадии, АГ 1-2 степени, риск 1-3; 4) стабильная АГ и регулярная антигипертензивная терапия в течение не менее 2 нед перед включением в исследование; 5) документированная БА. Для количественных переменных проводился анализ соответствия распределения нормальному закону. При сравнении показателей двух групп (АГ без БА и АГ+БА) проводилась поправка на пол, возраст. Исходные характеристики пациентов Для участия в исследовании было отобрано 125 больных, 28 мужчин (22%), 97 женщин (78%).

ЭБХ для ДАД
Прием препаратов для СД
Findings
Параметрические показатели
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call